Germany’s Stada aid buyout groups Bain Capital and Cinven were considering seeking regulatory clearance to make a new takeover offer for the generic drugmaker after their 5.3 billion euro ($6 billion) bid fell through.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
